Leukemia Fellowship

Thank you for your interest in the UT MD Anderson Leukemia Clinical Fellowship Program. 

As program director, I am proud to introduce one of the most comprehensive and academically rigorous training experiences in hematologic oncology. Our fellowship is designed to prepare physicians for excellence in the diagnosis, management, and investigational treatment of leukemia and related disorders. 

At UT MD Anderson, we are privileged to lead innovation in leukemia care, and our fellows are integral to that mission.  The fellowship curriculum offers immersive training across a broad spectrum of hematologic malignancies, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs). Fellows engage in high-volume clinical care, multidisciplinary collaboration, and active participation in clinical trials. In addition, our fellows are encouraged to pursue academic scholarships through research, presentations, and peer-reviewed publications.

Our alumni have gone on to lead leukemia programs at major institutions across the United States and around the world. Many international graduates have returned to their home countries, where they now serve as national experts — establishing leukemia treatment centers, shaping clinical guidelines, and expanding access to advanced therapies. 

We invite you to explore our program and discover how UT MD Anderson continues to shape the future of leukemia care through education, innovation, and global impact.

Warm regards,
Tapan M. Kadia, M.D.
Program Director, Leukemia Clinical Fellowship Program
Professor, Department of Leukemia
The University of Texas MD Anderson Cancer Center